E Welcome To 2021

Welcome to 2021. US stock markets tried and failed to start the year with a new high as it managed to close 2020 with the main reason fear of Covid-19. The everything rally has been canceled. Another reason: Trump's attempt to fiddle with Georgia's Presidential poll results may defeat Trump Republican candidates in tomorrow's by-election, giving Democrats control of both houses of Congress—and adding to the risks of inflation. Our dollar lost 6.7% in 2020. Today gold is at a quarterly new high up over 2%. Julian Assange will not be delivered to US Justice over his WikiLeaks.

Business newspaper article

image source


*This morning at the opening as per my note yesterday, I bought NovaCare, NVCR, at $170.54. Unfortunately, my cousin will not seek to use its electronic system to overcome her pancreatic cancer despite my urgings and since she is grown-up and older than me there I nothing I can do. The stock is down 6.5% from my price paid and well off from its 2020 high.

*The healthcare joint venture of Amazon, Berkshire Hathaway, and JP Morgan called Haven is shutting down after 3 years and the staff will be placed at different parent companies. They never worked well together in Boston as they were supposed to. Its CEO left in May and no replacement was named. This led to a selloff today in drug stocks.

*Abcellera Biologics fell another 2.99% to a new low of $38.9 (US). ABCL is Canadian and its IPO was boosted by Barron's because Peter Thiel is on its board.

*With the new variant covid-19 at epidemic proportions, Wall Street and foreign markets could not sustain the upward momentum from last year, but some pharma shares were in demandCanadian Zymeworks rose 5% at the opening to $50.6 (US) and while ZYME fell back to $49.53 it is still a harbinger of growth.

*Israeli Teva (the old TEVA) gained too, briefly back over $10, and now is at $9.95. Teva means health in Hebrew.

*Glaxo won a $162 mn contract US CDC for 2 years' pediatric flu vaccine. UK GSK gained 2.1%.

*Fellow Brit Astra-Zeneca rose 1.1% at the opening but then was chopped back ot a gain of 0.62%. The AZN-Oxford vaccine inoculated a dialysis patient at high risk, a first use, in Oxford today.

1 2 3 4
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.